LETTER
Response: GnRH-agonist administration in the luteal
phase of IVF cycles: still an experimental approach
To the Editor
We read with great interest the letter by
Vakalopoulos
and Zeginiadou (2010)
regarding our manuscript (
Isik
et al., 2009
). We completely agree that luteal GnRH agonist
administration for luteal support in antagonist cycles should
be considered as an experimental approach. On the other
hand, as we have mentioned in a previous letter (
Isik and
Caglar, 2010
), this approach deserves further investigation
both clinically and biologically.
References
Isik, A.Z., Caglar, G., 2010. Response: single dose GnRH agonist administration in the luteal phase of assisted reproduction cycles: is the effect dependent on the types of GnRH analogue used for pituitary suppression? Reprod. BioMed. Online 20, 167.
Isik, A.Z., Caglar, G.S., Sozen, E., et al., 2009. Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study. Reprod. BioMed. Online 19, 472–477.
Vakalopoulos, I., Zeginiadou, T., 2010. GnRH-agonist administration in the luteal phase of IVF cycles: still an experimental approach. Reprod. BioMed. Online 21, 148–149.
Gamze Caglar
Ufuk University School of Medicine,
Department of Obstetrics and Gynecology,
Division of Reproductive Endocrinology and Infertility,
Ankara, Turkey
E-mail address: gamzesinem@hotmail.com
A. Zeki Isik
Ankara Private IVF center,
Ankara, Turkey
1472-6483/$ - see front matterª 2010, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved. doi:10.1016/j.rbmo.2010.04.001
Reproductive BioMedicine Online (2010) 21, 150
w w w . s c i e n c e d i r e c t . c o m w w w . r b m o n l i n e . c o m